| Size | Price | |
|---|---|---|
| 500mg | ||
| 1g | ||
| Other Sizes |
| ln Vitro |
3'-Oxylutein (10 ng/μL, 10-30 min) significantly reduced the production of reactive oxygen species (ROS) in glutamate-induced SH-SY5Y cells [1]. 3'-Oxylutein (10 ng/μL, 24-72 h) increased the level of small molecule antioxidants at 48 h, but did not change the total antioxidant capacity (TAC) level in glutamate-treated SH-SY5Y cells [1]. 3'-Oxylutein alone (10 ng/μL, 24-72 h) did not change the activity of superoxide dismutase (SOD) or inhibit the decrease of SOD in glutamate-treated SH-SY5Y cells [1]. 3'-Oxylutein (10 ng/μL, 24-72 h) reduced the iron content in glutamate-induced SH-SY5Y cells [1]. 3'-Oxylutein (10 ng/μL, 24-72 h) can reduce the relative mRNA expression of glutamate-induced ALOX5, ALOX15 and ACSL4 genes in SH-SY5Y cells[1]. 3'-Oxylutein (10 ng/μL, 24-72 h) does not cause changes in IL-6 secretion in SH-SY5Y cells, but it can reduce glutamate-induced IL-8 secretion and reduce TNFα levels[1].
|
|---|---|
| Cell Assay |
Real-time quantitative PCR[1]
Cell Types: SH-SY5Y cells Tested Concentrations: 10 ng/μL Incubation Duration: 24, 48, 72 hours Experimental Experimental Results: Compared with glutamate-treated SH-SY5Y cells, the relative mRNA expression of ALOX5, ALOX15 and ACSL4 genes was reduced in OG1 and OG5 treatments. |
| References |
| Molecular Formula |
C40H54O2
|
|---|---|
| Molecular Weight |
566.86
|
| CAS # |
23984-55-6
|
| Appearance |
Typically exists as solids at room temperature
|
| SMILES |
CC1(C)C(/C=C/C(C)=C/C=C/C(C)=C/C=C/C=C(C)/C=C/C=C(C)/C=C/[C@@H]2C(C)(CC(C=C2C)=O)C)=C(C)C[C@@H](O)C1
|
| Synonyms |
3'-Dehydrolutein; Philosamiaxanthin
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
May dissolve in DMSO (in most cases), if not, try other solvents such as H2O, Ethanol, or DMF with a minute amount of products to avoid loss of samples
|
|---|---|
| Solubility (In Vivo) |
Note: Listed below are some common formulations that may be used to formulate products with low water solubility (e.g. < 1 mg/mL), you may test these formulations using a minute amount of products to avoid loss of samples.
Injection Formulations
Injection Formulation 1: DMSO : Tween 80： Saline = 10 : 5 : 85 (i.e. 100 μL DMSO stock solution → 50 μL Tween 80 → 850 μL Saline)(e.g. IP/IV/IM/SC) *Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH ₂ O to obtain a clear solution. Injection Formulation 2: DMSO : PEG300 ：Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL DMSO → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline) Injection Formulation 3: DMSO : Corn oil = 10 : 90 (i.e. 100 μL DMSO → 900 μL Corn oil) Example: Take the Injection Formulation 3 (DMSO : Corn oil = 10 : 90) as an example, if 1 mL of 2.5 mg/mL working solution is to be prepared, you can take 100 μL 25 mg/mL DMSO stock solution and add to 900 μL corn oil, mix well to obtain a clear or suspension solution (2.5 mg/mL, ready for use in animals). View More
Injection Formulation 4: DMSO : 20% SBE-β-CD in saline = 10 : 90 [i.e. 100 μL DMSO → 900 μL (20% SBE-β-CD in saline)] Oral Formulations
Oral Formulation 1: Suspend in 0.5% CMC Na (carboxymethylcellulose sodium) Oral Formulation 2: Suspend in 0.5% Carboxymethyl cellulose Example: Take the Oral Formulation 1 (Suspend in 0.5% CMC Na) as an example, if 100 mL of 2.5 mg/mL working solution is to be prepared, you can first prepare 0.5% CMC Na solution by measuring 0.5 g CMC Na and dissolve it in 100 mL ddH2O to obtain a clear solution; then add 250 mg of the product to 100 mL 0.5% CMC Na solution, to make the suspension solution (2.5 mg/mL, ready for use in animals). View More
Oral Formulation 3: Dissolved in PEG400 (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 1.7641 mL | 8.8205 mL | 17.6410 mL | |
| 5 mM | 0.3528 mL | 1.7641 mL | 3.5282 mL | |
| 10 mM | 0.1764 mL | 0.8821 mL | 1.7641 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
